An open-label single-arm, phase II trial of zalutumumab, a human monoclonal anti-EGFR antibody, in patients with platinum-refractory squamous cell carcinoma of the head and neck
Titel:
An open-label single-arm, phase II trial of zalutumumab, a human monoclonal anti-EGFR antibody, in patients with platinum-refractory squamous cell carcinoma of the head and neck
Auteur:
Saloura, Vassiliki Cohen, Ezra E. W. Licitra, Lisa Billan, Salem Dinis, Jose Lisby, Steen Gauler, Thomas C.